Lipid transporters: Membrane transport systems for cholesterol and fatty acids

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 3, Issue 4, 2000, Pages 255-262

  Abumrad, Nada A ^a   Sfeir, Zeina ^a   Connelly, Margery A ^a   Coburn, Chris ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; LIPID;

CHOLESTEROL TRANSPORT; DIFFUSION; FATTY ACID TRANSPORT; HUMAN; LIPID TRANSPORT; MEMBRANE TRANSPORT; NONHUMAN; PROTEIN BINDING; PROTEIN LIPID INTERACTION; REVIEW;

AMINO ACID SEQUENCE; ANTIGENS, CD36; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CELL MEMBRANE; CHOLESTEROL; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; HUMANS; LIPID METABOLISM; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; ORGANIC ANION TRANSPORTERS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LIPOPROTEIN; RECEPTORS, SCAVENGER; SCAVENGER RECEPTORS, CLASS B; TUMOR SUPPRESSOR PROTEINS;

EID: 0033929797     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-200007000-00003     Document Type: Review

References (76)

1. Kleinfeld AM, Chu P, Romero C. Transport of long-chain native fatty acids across lipid bilayer membranes indicates that transbilayer flip-flop is rate limiting. Biochemistry 1997; 36:14146-14158.
2. Bevers EM, Comfurius P, Dekkers DW, Zwaal RF. Lipid translocation across • the p̀lasma membrane of mammalian cells. Biochim Biophys Acta 1999; 1439:317-330. Current review that discusses phospholipid translocation and maintenance of membrane asymmetry.
3. Elferink RP, Groen AK. The mechanism of biliary lipid secretion and its defects. Gastroenterol Clin North Am 1999; 28:59-74.
4. Owen JS. Role of ABC1 gene in cholesterol efflux and atheroprotection. Lancet 1999; 354:1402-1403.
5. Marcil M, Brooks-Wilson A, Clee SM, et al. Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet 1999; 354:1341-1346.
6. Orso E, Broccardo C, Kaminski WE, et al. Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice. Nature Genet 2000; 24:192-196.
7. Kullak-Ublick GA, Beuers U, Paumgartner G. Hepatobiliary transport. J Hepatol 2000; 32:3-18.
8. Love MW, Dawson PA. New insights into bile acid transport. Curr Opin Lipidol 1998; 9:225-229.
9. Zsembery A, Thallamer T, Graf J. Bile formation: a concerted action of • membrane transporters in hepatocytes and cholangiocytes. News Physiol Sci 2000; 15:6-11. A comprehensive review that summarized progress related to the different transporters involved in bile formation.
10. Meier PJ, Eckhardt U, Schroeder A, et al. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver. Hepatology 1997; 26:1667-1677.
11. Kamisako T, Gabazza EC, Ishihara T, Adachi Y. Molecular aspects of organic compound transport across the plasma membrane of hepatocytes. J Gastroenterol Hepatol 1999; 14:405-412.
12. Oelkers P, Kirby LC, Heubi JE, Dawson PA. Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2). J Clin Invest 1997; 99:1880-1687.
13. Balistreri WF. Inborn errors of bile acid biosynthesis and transport. Novel forms of metabolic liver disease. Gastroenterol Clin North Am 1999; 28:145-172.
14. Schroeder F, Frolov AA, Murphy EJ, et al. Recent advances in membrane cholesterol domain dynamics and intracellular cholesterol trafficking. Proc Soc Exp Biol Med 1996; 213:150-177.
15. Luker GD, Nilsson KR, Covey DF, Piwnica-Worms D. Multidrug resistance (MDR1) P-glycoprotein enhances esterification of plasma membrane cholesterol. J Biol Chem 1999; 274:6979-6991.
16. Tall AR. An overview of reverse cholesterol transport. Eur Heart J 1998; 19(Suppl A):A31-A35.
17. Rigotti A, Krieger M. Getting a handle on 'good' cholesterol with the high-density lipoprotein receptor. N Engl J Med 1999; 341:2011-2013.
18. Acton S, Rigotti A, Landschulz KT, et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996; 271:518-520.
19. Acton SL, Kozarsky KF, Rigotti A. The HDL receptor SR-BI: a new therapeutic target for atherosclerosis? Mol Med Today 1999; 5:518-524.
20. de la Llera-Moya M, Rothblat GH, Connelly MA, et al. Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface. J Lipid Res 1999; 40:575-580.
21. Krieger M, Kozarsky K. Influence of the HDL receptor SR-BI on atherosclerosis. • Curr Opin Lipidol 1999; 10:491-497. An interesting review that describes the role of SR-BI in selective cholesterol uptake and discusses the implication of this function with respect to the pathogenesis of atherosclerosis.
22. Arai T, Wang N, Bezouevski M, et al. Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene. J Biol Chem 1999; 274:2366-2371.
23. Kozarsky KF, Donahee MH, Glick JM, et al. Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol 2000; 20:721-727.
24. Osgood-McWeeney D, Galluzzi JR, Ordovas JM. Allelic discrimination for single nucleotide polymorphisms in the human scavenger receptor class B type 1 gene locus using fluorescent probes. Clin Chem 2000; 46:118-119.
25. Acton S, Osgood D, Donoghue M, et al. Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. Arterioscler Thromb Vasc Biol 1999; 19:1734-1743.
26. Ibrahimi A, Sfeir Z, Magharaie H, et al. Expression of the CD36 homolog (FAT) in fibroblast cells: effects on fatty acid transport. Proc Natl Acad Sci USA 1996; 93:2646-2651.
27. Spady DK, Kearney DM, Hobbs HH. Polyunsaturated fatty acids up-regulate hepatic scavenger receptor B1 (SR-BI) expression and HDL cholesteryl ester uptake in the hamster. J Lipid Res 1999; 40:1384-1394.
28. Sun Y, Wang N, Tall AR. Regulation of adrenal scavenger receptor-BI expression by ACTH and cellular cholesterol pools. J Lipid Res 1999; 40:1799-1805.
29. Stangl H, Hyatt M, Hobbs HH. Transport of lipids from high and low density lipoproteins via scavenger receptor-BI. J Biol Chem 1999; 274:32692-32698.
30. Gu X, Lawrence R, Krieger M. Dissociation of the high density lipoprotein and low density lipoprotein binding activities of murine scavenger receptor class B type I (mSR-BI) using retrovirus library-based activity dissection. J Biol Chem 2000; 275:9120-9130.
31. Abumrad NA, Perkins RC, Park JH, Park CR. Mechanism of long chain fatty acid permeation in the isolated adipocyte. J Biol Chem 1981; 256:9183-9191.
32. Richieri GV, Ogata RT, Kleinfeld AM. The measurement of free fatty acid concentration with the fluorescent probe ADIFAB: a practical guide for the use of the ADIFAB probe. Mol Cell Biochem 1999; 192:87-94.
33. Richieri GV, Kleinfeld AM. Unbound free fatty acid levels in human serum. J Lipid Res 1995; 36:229-240.
34. Abumrad NA, Park JH, Park CR. Permeation of long-chain fatty acid into adipocytes. Kinetics, specificity, and evidence for involvement of a membrane protein. J Biol Chem 1984; 259:8945-8953.
35. Abumrad N, Harmon C, Ibrahimi A. Membrane transport of long-chain fatty acids: evidence for a facilitated process. J Lipid Res 1998; 39:2309-2318.
36. iRusso CC, Black PN. Long-chain fatty acid transport in bacteria and yeast. Paradigms for defining the mechanism underlying this protein-mediated process. Mol Cell Biochem 1999; 192:41-52.
37. Berk PD, Stump DD. Mechanisms of cellular uptake of long chain free fatty acids. Mol Cell Biochem 1999; 192:17-31.
38. Stump DD, Zhou SL, Berk PD. Comparison of plasma membrane FABP and mitochondrial isoform of aspartate aminotransferase from rat liver. Am J Physiol 1993; 265:G894-G902.
39. Isola LM, Zhou SL, Klang CL, et al. 3T3 fibroblasts transfected with a cDNA for mitochondrial aspartate aminotransferase express plasma membrane fatty acid-binding protein and saturable fatty acid uptake. Proc Natl Acad Sci USA 1995; 92:9866-9870.
40. Zhou SL, Stump D, Sorrentino D, et al. Adipocyte differentiation of 3T3-L1 cells involves augmented expression of a 43-kDa plasma membrane fatty acid-binding protein. J Biol Chem 1992; 267:14456-14461.
41. Berk PD, Zhou S, Kiang C, et al. Selective up-regulation of fatty acid uptake by adipocytes characterizes both genetic and diet-induced obesity in rodents. J Biol Chem 1999; 274:28626-28631.
42. Kiens B, Kristiansen S, Jensen P, et al. Membrane associated fatty acid binding protein (FABPpm) in human skeletal muscle is increased by endurance training. Biochem Biophys Res Commun 1997; 231:463-465.
43. Greenwalt DE, Lipsky RH, Ockenhouse CF, et al. Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood 1992; 80:1105-1115.
44. Harmon CM, Abumrad NA. Binding of sulfosuccinimidyl fatty acids to adipocyte membrane proteins: isolation and amino-terminal sequence of an 88-kD protein implicated in transport of long-chain fatty acids. J Membr Biol 1993; 133:43-49.
45. Abumrad NA, el-Maghrabi MR, Amri EZ, et al. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 1993; 268:17665-17668.
46. Harmon CM, Luce P, Abumrad NA. Labelling of an 88 kDa adipocyte membrane protein by sulpho-N-succinimidyl long-chain fatty acids: inhibition of fatty acid transport. Biochem Soc Trans 1992; 20:811-813.
47. Abumrad N, Coburn C, Ibrahimi A. Membrane proteins implicated in long-chain • fatty acid uptake by mammalian cells: CD36, FATP and FABPm. Biochim Biophys Acta 1999; 1441:4-13. Current review that summarizes progress related to membrane fatty acid transport and discusses among the proteins that have been implicated in the process, the three that have been the most characterized so far.
48. Febbraio M, Abumrad NA, Hajjar DP, et al. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 1999; 274:19055-19062.
49. Bonen A, Dyck DJ, Ibrahimi A, Abumrad NA. Muscle contractile activity increases fatty acid metabolism and transport and FAT/CD36. Am J Physiol 1999; 276:E642-E649.
50. Ibrahimi A, Bonen A, Blinn WD, et al. Muscle-specific overexpression of FAT/ CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin. J Biol Chem 1999; 274:26761-26766.
51. Nakata T, Nakahara N, Sohmiya K, et al. Scintigraphic evidence for a specific long-chain fatty acid transporting system deficit and the genetic background in a patient with hypertrophic cardiomyopathy. Jpn Circ J 1999; 63:319-322.
52. Nozaki S, Tanaka T, Yamashita S, et al. CD36 mediates long-chain fatty acid transport in human myocardium: complete myocardial accumulation defect of radiolabeled long-chain fatty acid analog in subjects with CD36 deficiency. Mol Cell Biochem 1999; 192:129-135.
53. Amri EZ, Bonino F, Ailhaud G, et al. Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors. J Biol Chem 1995; 270:2367-2371.
54. Tontonoz P, Nagy L. Regulation of macrophage gene expression by peroxisome-proliferator-activated receptor gamma: implications for cardiovascular disease. Curr Opin Lipidol 1999; 10:485-490.
55. Nagy L, Tontonoz P, Alvarez JG, et al. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 1998; 93:229-240.
56. van der Lee KA, Vork MM, De Vries JE, et al. Long-chain fatty acid-induced changes in gene expression in neonatal cardiac myocytes. J Lipid Res 2000; 41:41-47.
57. Aitman TJ, Glazier AM, Wallace CA, et al. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nature Genet 1999; 21:76-83.
58. Acton SL, Scherer PE, Lodish HF, Krieger M. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J Biol Chem 1994; 269:21003-21009.
59. Connelly MA, Klein SM, Azhar S, et al. Comparison of class B scavenger receptors, CD36 and scavenger receptor BI (SR-BI), shows that both receptors mediate high density lipoprotein-cholesteryl ester selective uptake but SR-BI exhibits a unique enhancement of cholesteryl ester uptake. J Biol Chem 1999; 274:41-47.
60. Calvo D, Gomez-Coronado D, Suarez Y, et al. Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. J Lipid Res 1998; 39:777-788.
61. Thompson JD, Higgins DG, Gibson TJ, Clustal W. Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994; 22:4673-4680.
62. Baillie AGS, Coburn CT, Abumrad NA. Reversible binding of long-chain fatty acids to purified FAT, the adipose CD36 homolog. J Membr Biol 1996; 153:75-81.
63. Rost B, Sander C, Schneider R. PHD: an automatic mail server for protein secondary structure prediction. Comput Appl Biosci 1994; 10:53-60.
64. Zanotti G, Scapin G, Spadon P, et al. Three-dimensional structure of recombinant human muscle fatty acid-binding protein. J Biol Chem 1992; 267:18541-18550.
65. Schaffer JE, Lodish HF. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell 1994; 79:427-436.
66. Hirsch D, Stahl A, Lodish HF. A family of fatty acid transporters conserved from mycobacterium to man. Proc Natl Acad Sci USA 1998; 95:8625-8629.
67. Stuhlsatz-Krouper SM, Bennett NE, Schaffer JE. Substitution of alanine for serine 250 in the murine fatty acid transport protein inhibits long chain fatty acid transport. J Biol Chem 1998; 273:28642-28650.
68. Watkins PA, Pevsner J, Steinberg SJ. Human very long-chain acyl-CoA synthetase and two human homologs: initial characterization and relationship to fatty acid transport protein. Prostaglandins Leukot Essent Fatty Acids 1999; 60:323-328.
69. Coe NR, Smith AJ, Frohnert BI, et al. The fatty acid transport protein (FATP1) is a very long chain acyl-CoA synthetase. J Biol Chem 1999; 274:36300-36304.
70. Gargiulo CE, Stuhlsatz-Krouper SM, Schaffer JE. Localization of adipocyte long-chain fatty acyl-CoA synthetase at the plasma membrane. J Lipid Res 1999; 40:881-892.
71. Hui TY, Frohnert BI, Smith AJ, et al. Characterization of the murine fatty acid transport protein gene and its insulin response sequence. J Biol Chem 1998; 273:27420-27429.
72. Frohnert BI, Hui TY, Bernlohr DA. Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene. J Biol Chem 1999; 274:3970-3977.
73. Schroeder A, Eckhardt U, Stieger B, et al. Substrate specificity of the rat liver Na(+)-bile salt cotransporter in Xenopus laevis oocytes and in CHO cells. Am J Physiol 1998; 274:G370-G375.
74. Moynault A, Luciani MF, Chimini G. ABC1, the mammalian homologue of the engulfment gene ced-7, is required during phagocytosis of both necrotic and apoptotic cells. Biochem Soc Trans 1998; 26:629-635.
75. Kellner-Weibel G, de La Llera-Moya M, Connelly MA, et a/. Expression of scavenger receptor BI in COS-7 cells alters cholesterol content and distribution. Biochemistry 2000; 39:221-229.
76. Spitsberg VL, Matitashvili E, Gorewit RC. Association and coexpression of fatty-acid-binding protein and glycoprotein CD36 in the bovine mammary gland. Eur J Biochem 1995; 230:872-878.